Welcome https://www.the-microbiologist.com. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Register
  • Sign In
  • Subscribe
Search our site
Menu
Close menu
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
    • Back to parent navigation item
    • Topics
    • Early Career Research
    • One Health
    • Food Security
    • Climate Action
    • Healthy Land
    • Clean Water
    • Economic Equality
    • Ocean Sustainability
  • Regions
    • Back to parent navigation item
    • Regions
    • Africa & Middle East
    • Asia & Oceania
    • The Americas
    • UK & Europe
    • USA & Canada
  • Videos
  • AMI
    • Back to parent navigation item
    • AMI
    • Community
    • Policy
    • Publishing
    • Events
    • Special Issues
    • Diversity & Inclusion
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
      • Early Career Research
      • One Health
      • Food Security
      • Climate Action
      • Healthy Land
      • Clean Water
      • Economic Equality
      • Ocean Sustainability
  • Regions
      • Africa & Middle East
      • Asia & Oceania
      • The Americas
      • UK & Europe
      • USA & Canada
  • Videos
  • AMI
      • Community
      • Policy
      • Publishing
      • Events
      • Special Issues
      • Diversity & Inclusion
  • More from navigation items

Latest news

Low-Res_Picture_MOPelanek_2

Malaria shaped distribution of early human populations

2026-04-23T13:25:00+01:00

Scientists investigated whether Plasmodium falciparum induced malaria shaped human habitat choice between 74,000 and 5,000 years ago, finding that malaria influenced habitat choice by pushing human groups away from high-risk environments and separating populations across the landscape. 

Paxlovid

COVID antiviral speeds recovery but doesn’t reduce hospitalization in vaccinated patients, trials find

2026-04-23T10:03:00+01:00

Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials.

Diffuse_proliferative_lupus_nephritis_-a-_very_high_mag

High levels of gut bacterial toxin trigger lupus nephritis

2026-04-23T09:53:00+01:00

Research suggests that using antibiotics to target the Ruminococcus gnavus lipoglycan, or the protein it activates on immune cell surfaces to amplify damaging inflammation, could serve as an alternative to current lupus nephritis therapies that suppress the immune system.

pexels-kindelmedia-8172607

Secret to a healthy liver found in a young microbiome

2026-04-23T09:40:00+01:00

Restoring the gut microbiome to its youthful state may hold the key to slowing aging and preventing liver cancer, one of the fastest-growing cancers worldwide, according to a study.

Cardioderma_cor_466457192

Scientists find a new way coronaviruses can get into human cells

2026-04-23T09:33:00+01:00

An international team of researchers has identified an East African bat coronavirus capable of entering human cells.  Whilst the virus can bind to a cell receptor found in the human lung, preliminary testing in Kenya suggests it has not spilled over into the local human population.

joseph-costa-TqS6pLZ0X-8-unsplash

Researchers fight oral cancer with bioengineered chewing gum

2026-04-23T09:18:00+01:00

Research shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.

All news content

Research

Low-Res_Picture_MOPelanek_2

Malaria shaped distribution of early human populations

2026-04-23T13:25:00+01:00

Scientists investigated whether Plasmodium falciparum induced malaria shaped human habitat choice between 74,000 and 5,000 years ago, finding that malaria influenced habitat choice by pushing human groups away from high-risk environments and separating populations across the landscape. 

Paxlovid

COVID antiviral speeds recovery but doesn’t reduce hospitalization in vaccinated patients, trials find

2026-04-23T10:03:00+01:00

Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials.

Diffuse_proliferative_lupus_nephritis_-a-_very_high_mag

High levels of gut bacterial toxin trigger lupus nephritis

2026-04-23T09:53:00+01:00

Research suggests that using antibiotics to target the Ruminococcus gnavus lipoglycan, or the protein it activates on immune cell surfaces to amplify damaging inflammation, could serve as an alternative to current lupus nephritis therapies that suppress the immune system.

More Research

Industry

Low-Res_Infectious Disease- TB and Non-TB- Scientists- Dartois and Dick- Lab-Office (33)

CDI breakthroughs lead to new drug development deal for deadly NTM bacteria

2026-04-22T09:11:00+01:00

Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG. 

Low-Res_mev2

Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment

2026-04-07T09:40:00+01:00

The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.

Laboratory Decontamination (Environment System) (4)

Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI

2026-03-24T12:23:00+00:00

UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.

more industry

Special Issue

Innovation

joseph-costa-TqS6pLZ0X-8-unsplash

Researchers fight oral cancer with bioengineered chewing gum

2026-04-23T09:18:00+01:00

Research shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.

pexels-teona-swift-6913399

Metagenomic software advance boosts research into microbial diversity

2026-04-22T11:37:00+01:00

Researchers studying the diversity of microbes in environmental samples now have access to a new tool that opens the door to cheaper, more accessible analysis of their samples.

Low-Res_Figure 1

Researchers combine polarized light and a magnetic field to spot malaria under the microscope

2026-04-22T09:54:00+01:00

Researchers have developed a new microscopy method that uses a magnetic field and polarized light to provide quantitative measurements that could enable faster and more objective detection of malaria in blood.

more innovation

People

HIV-budding-Color (1)

WHO certifies the Bahamas for eliminating mother-to-child transmission of HIV

2026-04-23T08:23:00+01:00

In a landmark achievement for Caribbean public health, the World Health Organization (WHO) congratulates The Bahamas for becoming the latest Caribbean nation to be certified as having eliminated the mother-to-child transmission of HIV.

Be_wise,_immunize_161003-F-AG923-0007

Flu vaccine no longer required for U.S. military

2026-04-22T15:31:00+01:00

The U.S. military is ending its long-standing requirement that service members receive the annual flu shot, a decision announced by Defense Secretary Pete Hegseth.

roizmanjpeg_smaller

Pioneering virologist Bernard Roizman dies at 96

2026-04-22T15:25:00+01:00

Bernard Roizman, ScD, world-leading expert on herpes simplex virus (HSV) and Joseph Regenstein Distinguished Service Professor Emeritus of Microbiology and Molecular Genetics and Cell Biology at The University of Chicago, died on April 13, 2026, at the age of 96. 

more people

  • Issues
  • Contact us
  • Topics A-Z
  • Writers A-Z
  • Advertise with us
  • Editorial Team
  • In the Loop Newsletter

Bringing the international microbiology community together to advance scientific impact.
appliedmicrobiology.org

© Applied Microbiology International
  • Cookie Policy
  • Privacy
  • Terms of use
  • © 2022 The Microbiologist

Site powered by Webvision Cloud